Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 63.20
-2.30 (-3.51%)
At close: Feb 13, 2026
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 32.73 billion as of February 13, 2026.
Market Cap
32.73B
Enterprise Value
32.62B
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
63.20
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has increased from 13.62B to 32.73B, an increase of 140.30%. That is a compound annual growth rate of 1,339.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 33.93B | -7.09% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OneRobotics (Shenzhen) | 43.38B |
| China Medical System Holdings | 36.71B |
| Simcere Pharmaceutical Group | 32.05B |
| China Resources Pharmaceutical Group | 29.40B |
| Grand Pharmaceutical Group | 27.24B |
| The United Laboratories International Holdings | 25.79B |
| Sunshine Lake Pharma | 25.53B |
| Ab&B Bio-Tech CO., LTD. JS | 19.49B |